Differential Effects of Oral Doxercalciferol (Hectorol®) or Paricalcitol (Zemplar®) in the Cyp27b1-Null Mouse Model of Uremia

René St-Arnaud,Alice Arabian,Omar Akhouayri,Joyce C. Knutson,Stephen A. Strugnell

Differential Effects of Oral Doxercalciferol (Hectorol®) or Paricalcitol (Zemplar®) in the Cyp27b1-Null Mouse Model of Uremia

2011

René St-Arnaud
Alice Arabian
Omar Akhouayri
Joyce C. Knutson
Stephen A. Strugnell

Background/Aims: Kidney disease patients experience declining calcitriol levels and develop secondary hyperparathyroidism (SHPT). Animal models of uremia based on 5/6 nephrectomy (N

Keywords:

Paricalcitol
Endocrinology
Vitamin D and neurology
Internal medicine
Calcitriol
Secondary hyperparathyroidism
Doxercalciferol
Kidney disease
Nephrectomy
Uremia
Biology
Parathyroid hormone

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations